• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    (TSX:BLCO)

    23.98 +0.03 (+0.13%)
    Streaming Delayed Price Updated: 10:01 AM EDT, Sep 16, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about BLCO

    < Previous 1 2 3 4 5 Next >
    News headline image
    Bausch Health’s Bausch + Lomb to Acquire Novartis’ XIIDRA(R)
    Via ACCESSWIRE
    News headline image
    Bausch + Lomb Will Acquire XIIDRA®
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb Launches PreserVision® AREDS 2 Formula Soft Gels Plus CoQ10 in the United States
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb Announces New Scientific Data and Analyses Featuring Consumer, Vision Care and Pharmaceutical Products Will Be Presented During American Optometric Association's Optometry's Meeting
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb Launches Biotrue® Hydration Boost Contact Lens Rehydrating Drops in the United States
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb Launches Bausch + Lomb INFUSE® Multifocal Silicone Hydrogel Contact Lenses in the United States
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb Announces Key Leadership Changes
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb and Novaliq Announce FDA Approval of MIEBO™ (Perfluorohexyloctane Ophthalmic Solution) for the Treatment of the Signs and Symptoms of Dry Eye Disease
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb Announces First-Quarter 2023 Results and Provides 2023 Guidance
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb Releases Annual Environmental, Social and Governance Report
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb Announces the Presentation of New Scientific Data on Products and Pipeline Programs at the American Society of Cataract and Refractive Surgery Annual Meeting
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb Announces 2023 Annual Meeting of Shareholder Results
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb Announces U.S. Launch of StableVisc™ Cohesive Ophthalmic Viscosurgical Device and TotalVisc™ Viscoelastic System
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb Announces the Presentation of New Data on Products and Pipeline Programs at the Association for Research in Vision and Ophthalmology Meeting
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb Reports More Than 65 Million Units of Contact Lens, Eye Care and Lens Care Materials Recycled Through ONE by ONE and Biotrue® Eye Care Recycling Programs
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb Will Release First-Quarter 2023 Financial Results on May 3
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb and Heidelberg Engineering Announce the Introduction of SeeLuma™ Fully Digital Surgical Visualization Platform
    From Bausch + Lomb
    Via Business Wire
    News headline image
    Bausch + Lomb Appoints Bob Bailey as Executive Vice President and Chief Legal Officer and Andrew Stewart as President, Ophthalmic Pharmaceuticals
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb and Novaliq Announce Publication of Second Pivotal Phase 3 Data on NOV03 (Perfluorohexyloctane) in American Journal of Ophthalmology
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb Announces Fourth-Quarter and Full-Year 2022 Results
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb Appoints Brent Saunders as Chief Executive Officer and Chair of the Board of Directors, Effective March 6, 2023
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    New Bausch + Lomb Social Media Campaign Highlights What ‘Sights’ Inspire AMD Patients
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb and Modulight Announce FDA Approval of ML6710i Photodynamic Laser for Use with Bausch + Lomb’s VISUDYNE® (Verteporfin for Injection)
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2022 Financial Results on February 22
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb Acquires AcuFocus, Inc.
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb Introduces Enhanced PreserVision® AREDS 2 Formula Mini Soft Gels with OCUSorb™
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb Publishes Update Presentation for the 41st Annual J.P. Morgan Healthcare Conference
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb Announces Participation at the 41st Annual J.P. Morgan Healthcare Conference
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb and Novaliq Announce Publication of Pivotal Phase 3 Data on NOV03 (Perfluorohexyloctane) in Ophthalmology
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb and Glaucoma Research Foundation Announce Launch of Screen, Protect, Cure Campaign In Recognition of Glaucoma Awareness Month
    From Bausch + Lomb Corporation
    Via Business Wire
    < Previous 1 2 3 4 5 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.